Login
Email: 
Password: 

Remember me 
| Register
top-left
top-right
Change the Business Plan in Response to a Changing Environment
Description
Surromed had to change their business plan due to two reasons, says Ringold:

1) External climate

2) Lack of potential partner interest. All good startups will adapt the business plan in their life, he notes. For example, Surromed shifted to a product revenue generating model. They started to provide a service to make money which they could invest in their own discoveries. The company moved from generating equity capital to generating revenue.
Gordon Ringold Biography
Dr. Ringold was most recently CEO of the Glaxo-Wellcome Group's Affymax Research Institute, where he managed the development of novel technologies to accelerate the pace of drug discovery. He is a co-founder and director of Maxygen Corporation, a Managing Partner of Technogen Associates, L.P., a private investment firm, and has over fifteen years of experience managing the discovery and development of pharmaceuticals and novel, enabling life science technologies. Prior to Affymax, Dr. Ringold served as Director and Vice President of the Institute for Cancer and Developmental Biology at Syntex, now a division of Hoffman La-Roche. Dr. Ringold received his B.A. in Biology from UC Santa Cruz, and his Ph.D. in Microbiology from UC San Francisco. He was on the faculty of the Department of Pharmacology at the Stanford University School of Medicine, and is currently a consulting professor there.
Surromed
Entrepreneurial Thought Leader Lectures
2003-02-26 4min 3sec ID: 413 Rating: 

Creative Commons License Stanford ECorner is licensed under Creative Commons.
For more details visit
our terms of use page.
bottom-left
bottom-left
Statistics
Loading statistics data please wait...